Boiron SA (FR:BOI)
PARIS:BOI
Holding FR:BOI?
Track your performance easily

Boiron SA (BOI) Stock Price & Analysis

5 Followers

BOI Stock Chart & Stats


Options Prices

Currently, No data available
---

Ownership Overview

0.83%<0.01%98.86%
Insiders
<0.01% Other Institutional Investors
98.86% Public Companies and
Individual Investors

BOI FAQ

What was Boiron SA’s price range in the past 12 months?
Boiron SA lowest stock price was €29.30 and its highest was €43.96 in the past 12 months.
    What is Boiron SA’s market cap?
    Currently, no data Available
    When is Boiron SA’s upcoming earnings report date?
    Boiron SA’s upcoming earnings report date is Mar 12, 2025 which is in 130 days.
      How were Boiron SA’s earnings last quarter?
      Boiron SA released its earnings results on Sep 19, 2024. The company reported €0.192 earnings per share for the quarter, beating the consensus estimate of N/A by €0.192.
        Is Boiron SA overvalued?
        According to Wall Street analysts Boiron SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Boiron SA pay dividends?
          Boiron SA pays a Annually dividend of €1.35 which represents an annual dividend yield of 4.25%. See more information on Boiron SA dividends here
            What is Boiron SA’s EPS estimate?
            Boiron SA’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Boiron SA have?
            Boiron SA has 17,545,408 shares outstanding.
              What happened to Boiron SA’s price movement after its last earnings report?
              Boiron SA reported an EPS of €0.192 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Boiron SA?
                Currently, no hedge funds are holding shares in FR:BOI
                ---

                Boiron SA Stock Smart Score

                10
                Unlock Smart Score
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Fundamentals

                Return on Equity
                5.13%
                Trailing 12-Months
                Asset Growth
                -25.92%
                Trailing 12-Months

                Company Description

                Boiron SA

                Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Boiron SA
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis